Mycenax Biotech Inc. (4726) Stock Price & Analysis
4726 Stock Chart & Stats
- Day’s Range
- TWD 19.95 - TWD 21.00
- 52-Week Range
- TWD 19.95 - TWD 37.00
- Previous Close
- TWD 21.00
- Volume
- N/A
- Average Volume (3M)
- 101.79K
- Market Cap
- TWD 4.29B
- Enterprise Value
- TWD 6.16B
- Total Cash (Recent Filing)
- TWD 264.94M
- Total Debt (Recent Filing)
- TWD 1.12B
- Price to Earnings (P/E)
- ―
- Beta
- 0.39
- Next Earnings
- Nov 18, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
4726 FAQ
What was Mycenax Biotech Inc.’s price range in the past 12 months?
What is Mycenax Biotech Inc.’s market cap?
When is Mycenax Biotech Inc.’s upcoming earnings report date?
How were Mycenax Biotech Inc.’s earnings last quarter?
Is Mycenax Biotech Inc. overvalued?
Does Mycenax Biotech Inc. pay dividends?
What is Mycenax Biotech Inc.’s EPS estimate?
How many shares outstanding does Mycenax Biotech Inc. have?
What happened to Mycenax Biotech Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Mycenax Biotech Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Mycenax Biotech Inc.
Mycenax Biotech Inc. specializes in the research, development, and manufacturing of biopharmaceutical products, leveraging both mammalian and microbial cell culture systems. Its market reach extends across Taiwan, Europe, Asia, and the United States. The company cultivates a diverse portfolio of advanced biological therapeutics and components. This includes monoclonal antibodies, bi-specific antibodies, Fc-fusion proteins, recombinant proteins, peptides, non-toxic protein conjugates, antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), in addition to plasmids and DNA vaccines. Beyond product innovation, Mycenax offers a comprehensive suite of process development solutions. These encompass the establishment of production cell lines, optimization of upstream and downstream processes, industrial scale-up, formulation science, and the creation of analytical methods. The firm also provides in-house analytical testing, Good Manufacturing Practice (GMP)-compliant manufacturing services for drug substances and finished products, and cell banking, all underpinned by its specialized manufacturing technologies. Established in 2001, Mycenax Biotech Inc. is headquartered in Zhubei, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Pei-Jiun Chen
- Employees
- 387
- Website
- www.mycenax.com
- Address
- No. 66, Shengyi 2nd Road, Zhubei, 302041, TW
Mycenax Biotech Inc. (4726) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |

